SCHEMBL8990259

SCHEMBL8990259

O=C(CCl)C1(F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22234676 0.84
SCHEMBL23366976 0.72
SCHEMBL22472300 0.72
Hydrochloric Acid SCHEMBL23354162 0.70
SCHEMBL19900306 0.70 LDHA (0.40)
SCHEMBL2013537 0.69
SCHEMBL22234952 0.69 TSHR (0.30)
SCHEMBL231971 0.67
SCHEMBL23009419 0.67
SCHEMBL18367054 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163078-A1 IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Shanghai Simr Biotechnology Co., Ltd. (CN) 2025-05-22 US disclosed
EP-4484433-A1 IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF Shanghai Simr Biotechnology Co., Ltd. (CN) 2025-01-01 EP disclosed
WO-2024217500-A1 ISOQUINOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海赛默罗生物科技有限公司 2024-10-24 WO disclosed
CN-118359538-A Isoquinoline compound, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-07-19 CN disclosed
CN-116693555-A Imidazopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2023-09-05 CN disclosed
WO-2023160475-A1 IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 上海赛默罗生物科技有限公司 2023-08-31 WO disclosed
CN-112088160-B 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives UCB生物制药有限责任公司 2023-07-04 CN disclosed
EP-3790885-B1 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES UCB Biopharma SRL (BE) 2023-04-19 EP disclosed
US-11286266-B2 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives UCB Biopharma SRL 2022-03-29 US disclosed
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed
US-20210107922-A1 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE) (BE) 2021-04-15 US disclosed
EP-3790885-A1 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES UCB Biopharma SRL (BE) 2021-03-17 EP disclosed
WO-2019215062-A1 1-IMIDAZOTHIADIAZOLO-2H-PYRROL-5-ONE DERIVATIVES UCB BIOPHARMA SPRL (BE) 2019-11-14 WO disclosed
WO-1996036635-A1 OXIRANYL-TRIAZOLES BAYER AKTIENGESELLSCHAFT (DE) 1996-11-21 WO disclosed
WO-1996036634-A1 OXIRANYL-HYDROXYETHYL TRIAZOLES BAYER AKTIENGESELLSCHAFT (DE) 1996-11-21 WO disclosed
EP-0560109-B1 Process for the preparation of 1-fluorocyclopropyl-methyl-ketone BAYER AG (DE) 1996-07-17 EP disclosed
EP-0710642-A2 Halogenoketones BAYER AG (DE) 1996-05-08 EP disclosed
US-5371295-A Process for preparing 1-fluorocyclopropyl methyl ketone BAYER AKTIENGESELLSCHAFT (DE) 1994-12-06 US disclosed
US-5336809-A Process for preparing 1-fluorocyclopropyl methyl ketone BAYER AKTIENGESELLSCHAFT (DE) 1994-08-09 US disclosed
EP-0560109-A2 Process for the preparation of 1-fluorocyclopropyl-methyl-ketone BAYER AG (DE) 1993-09-15 EP disclosed